Inflexion is pleased to announce that it has agreed to partner with GlobalData Plc (“GlobalData”) to carve out its Healthcare division as a standalone entity in a transaction valuing the business at £1.1 billion. The investment is being made by Inflexion’s dedicated minority equity strategy, Partnership Capital.
The healthcare data business is the largest division of AIM-listed GlobalData, headquartered in the UK and employing over 1,000 people across 10 countries. Its subscription service offers a one-stop data solution for over 2,000 global customers across large global pharma, pharma & biotech, pharma suppliers, professional services and medical devices manufacturers.
This innovative transaction allows GlobalData to retain a majority stake in the business. GlobalData and Inflexion will work together to accelerate organic growth primarily through securing new clients globally and further cross-selling to existing clients, continuing to invest in the product and content, as well as pursuing selective M&A.
Inflexion’s Partnership Capital Fund has a strong track record in leading corporate partnerships and carve-outs including the recently announced carve-out of aosphere with global law firm Allen & Overy. Others have included partnering with Informa PLC to create Curinos, a global financial data provider, and partnering with the Daisy Group to create Giacom, a platform software business created in 2021.